“driving with dementia”的搜索结果，显示 121-130 项，共有 564 项

1. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to learn more about amyloid and tau burden in the brain of patients with Atypical Alzheimer's Disease and how that burden may ...

2. 神经科- 临床试验- 妙佑医疗国际

   ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...

3. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to investigate whether recent, groundbreaking discoveries about key pathophysiologic processes that drive chronic dizziness in ...

4. 神经科- 临床试验- 妙佑医疗国际

   Cerebrospinal Fluid (CSF) Biomarkers for Prediction of Dementia. Rochester, Minn., Jacksonville, Fla. To further investigate biomarkers in CSF as possible ...

5. 神经科- 临床试验- 妙佑医疗国际

   Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to characterize the astrocyte response to various inflammatory drivers in the presence of innate immune cells collected from ...

7. 神经科- 临床试验- 妙佑医疗国际

   A Study Evaluating the Use of 48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease. Jacksonville, Fla. The purpose of this study is to ...

8. 神经科- 临床试验- 妙佑医疗国际

   Cerebrospinal Fluid (CSF) Biomarkers for Prediction of Dementia. Rochester, Minn., Jacksonville, Fla. To further investigate biomarkers in CSF as possible ...

9. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to learn more about amyloid and tau burden in the brain of patients with Atypical Alzheimer's Disease and how that burden may ...

10. 神经科- 临床试验- 妙佑医疗国际

    Cerebrospinal Fluid (CSF) Biomarkers for Prediction of Dementia. Rochester, Minn., Jacksonville, Fla. To further investigate biomarkers in CSF as possible ...